SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-029381
Filing Date
2020-06-15
Accepted
2020-06-15 16:45:23
Documents
5
Period of Report
2020-06-10
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K - AGM RESOLUTIONS itrm-8k_20200610.htm 8-K 85184
2 EX-3.1 itrm-ex31_10.htm EX-3.1 787842
3 EX-99.1 itrm-ex991_9.htm EX-99.1 196437
4 EX-99.2 itrm-ex992_8.htm EX-99.2 19597
5 GRAPHIC gik1120pyqxa000001.jpg GRAPHIC 7989
  Complete submission text file 0001564590-20-029381.txt   1101858
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 20963929
SIC: 2834 Pharmaceutical Preparations